ARWR – arrowhead pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $110.00 price target on the stock, up previously from $100.00.
Is Arrowhead Pharmaceuticals Stock a Buy or Sell After the CEO Sold Shares Worth $5.4 Million? [Yahoo! Finance]
Assessing Arrowhead Pharmaceuticals (ARWR) Valuation After REDEMPLO Approvals And New Obesity Trial Data [Yahoo! Finance]
Arrowhead Pharmaceuticals Prices Offerings of Notes, Common Stock, Pre-Funded Warrants [Yahoo! Finance]
Arrowhead Pharmaceuticals Prices Upsized Offerings of Convertible Senior Notes, Common Stock and Pre-Funded Warrants
Form 8-K ARROWHEAD PHARMACEUTICAL For: Jan 12
Form 8-K ARROWHEAD PHARMACEUTICAL For: Jan 07
Form 424B5 ARROWHEAD PHARMACEUTICAL
Form 424B5 ARROWHEAD PHARMACEUTICAL
Form 4 ARROWHEAD PHARMACEUTICAL For: Jan 06 Filed by: Hamilton James C
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.